Why MacroGenics Stock Is Skyrocketing Today
Shares of MacroGenics (NASDAQ: MGNX) were skyrocketing 27.8% higher as of 12:47 p.m. ET on Tuesday. A filing to the U.S. Securities and Exchange Commission on June 17 revealed that MacroGenics CFO James Karrels recently bought 40,000 shares. It's not unusual for clinical-stage biotech stocks to jump when key insiders buy shares.